RPL36A

Large ribosomal subunit protein eL42 (60S rib · P83881 · RPL36A on Sugi Atlas →

0 patent compounds predicted against RPL36A, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RPL36A by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From Real World PHASE4UNKNOWN
COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES PHASE3UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant PHASE2COMPLETED
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis PHASE1/PHASE2COMPLETED
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors PHASE1COMPLETED
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE1WITHDRAWN
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients PHASE1UNKNOWN
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Quantification of GADD34 Expression in RA nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants nanCOMPLETED
Proteomic Profiling to Reveal Novel Prognostic Markers for Neurological Outcome Following Resuscitation nanCOMPLETED
Proteomics and Orthodontic Root Resorption nanCOMPLETED
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages nanCOMPLETED
Genetic Variants in Linear Localized Scleroderma nanCOMPLETED
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a RPL36A binder may also engage these)

ProteinNameSimilarity
Q3SZ59 1.000 Q3SZ59 →
D0VWQ4 1.000 D0VWQ4 →
P83884 1.000 P83884 →
P83883 1.000 P83883 →
Q969Q0 1.000 Q969Q0 →
Q5R9D2 1.000 Q5R9D2 →
P61485 1.000 P61485 →
Q8SR18 1.000 Q8SR18 →
P83882 1.000 P83882 →
Q55CW5 1.000 Q55CW5 →
P49213 1.000 P49213 →
Q9UWE4 1.000 Q9UWE4 →
Q9NB33 1.000 Q9NB33 →
P54027 1.000 P54027 →
O28936 1.000 O28936 →
P52809 1.000 P52809 →
P61487 1.000 P61487 →
P48166 1.000 P48166 →
P27074 1.000 P27074 →
P31028 1.000 P31028 →
P90702 1.000 P90702 →
P27075 0.999 P27075 →
P61486 0.998 P61486 →
Q6CFS7 0.998 Q6CFS7 →
A0A1D8PEV4 0.998 A0A1D8PEV4 →
O97231 0.998 O97231 →
Q5JE51 0.997 Q5JE51 →
P31027 0.997 P31027 →
Q9HIX1 0.997 Q9HIX1 →
Q96499 0.996 Q96499 →